Filing Details

Accession Number:
0001567619-20-014729
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-11 16:06:50
Reporting Period:
2020-08-07
Accepted Time:
2020-08-11 16:06:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1776564 Sa Dimitry Nuyten C/O Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley CA 94710
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-07 3,538 $2.55 8,462 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.